MTI-31, CAS [[1567915-38-1]]

Produktübersicht

• Artikelname: MTI-31, CAS [[1567915-38-1]]
• Artikelnummer: MCE-HY-126077
• Hersteller Artikelnummer: HY-126077
• Alternativnummer: MCE-HY-126077-25MG,MCE-HY-126077-10MG,MCE-HY-126077-5MG,MCE-HY-126077-1MG,MCE-HY-126077-50MG,MCE-HY-126077-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: LXI-15029

Produktbeschreibung

MTI-31 (LXI-15029) is a potent, orally active and highly selective inhibitor of mTORC1 and mTORC2. MTI-31 is selective for mTOR (Kd: 0.20 nM) versus PIK3CA, PIK3CB and PIK3G with >5,000 fold selectivity in mTOR binding assays. MTI-31 shows an IC50 of 39 nM for mTOR in LANCE assay of mTOR substrate phosphorylation with 100 µM ATP. MTI-31 can be used for the research of breast cancer[1].

Produkteigenschaften

• Molekulargewicht: 474.55
• Reinheit: 99.98
• CAS Nummer: [1567915-38-1]
• Formel: C26H30N6O3
• Target-Kategorie: mTOR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound1